Clinical Oncology Next Generation Sequencing (NGS) Market 2019 Detailed Industry Report Covering Leading Players DNASTAR Inc., Roche, Illumina Inc., Agilent Technologies, Qiagen NV

The Global Clinical Oncology Next Generation Sequencing (NGS) Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025. Global clinical oncology NGS market is driven by rapid technological advances in genomic technologies and sequencing platforms.

For Sample Copy of this Report @ https://www.orianresearch.com/request-sample/804110

Rise in adoption of sequencing-based diagnostics platforms among practicing oncologists, exponential decrease in the costs for genetic sequencing would significantly propel the market growth.

Factors, such as time consuming process and data interpretation is expected to act as major restrain in the growth of the market.

Loans and grants provided by governments for the purpose of research and development is also expected to propel the market’s growth in the near future.

On the basis of technology, the global market has been segmented into whole genome sequencing, targeted sequencing & resequencing, and whole exon sequencing. The metallic whole genome sequencing segment is expected to account for major share in terms of revenue in the global clinical oncology next generation sequencing market.

On the basis of workflow, the global market has been segmented into NGS data analysis, NGS pre-sequencing, AND NGS sequencing.

Regionally North America is expected to emerge as a prominent region supplementing the market’s growth owing to strategic initiatives taken up by the governments in the region. Other regions are also anticipated to support the growth of the market with early adoption of the technologies.

Some of the key players operating in this market include DNASTAR Inc., Roche, Illumina Inc., Agilent Technologies, Qiagen NV, CLC Bio, Biomatters Ltd., and Pacific Bioscience, Perkin Elmer Inc.

Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/804110

Key benefits of the report:

• Global, Regional, Country, Technology, and Route of Work flowMarket Size and Forecast from 2014-2025
• Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
• Identification of key companies that can influence this market on a global and regional scale
• Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
• Detailed insights on emerging regions, Technology& Work flow, and competitive landscape with qualitative and quantitative information and facts

Target Audience:

• Clinical Oncology Next Generation Sequencing (NGS) providers
• Traders, Importer and Exporter
• Raw material suppliers and distributors
• Research and consulting firms
• Government and research organizations
• Associations and industry bodies

Get Direct Copy of this Report @ https://www.orianresearch.com/checkout/804110

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity Work flow, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
• Hospital
• Clinics
• Government Body & Associations, and
• Research Institute
• Pharmacies

About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:
Ruwin Mendez
Vice President – Global Sales & Partner Relations
Orian Research Consultants
US: +1 (415) 830-3727 | UK: +44 020 8144-71-27
Email: info@orianresearch.com
Website: www.orianresearch.com/
Follow Us on LinkedIn: https://www.linkedin.com/company-beta/13281002/

This release was published on openPR.